Recombinant Anti-CCR3 x Anti-CD300 Bispecific Antibody (IgG-Fv) (BSGV-028)

Recombinant Anti-CCR3 x Anti-CD300 Bispecific Antibody (IgG-Fv) is formed by an Immunoglobulin G (IgG) and a fragment variable Fv region, in which the Fc of IgG is engineered by KIH. The Fv region of an anti-CCR3 antibody variable domain is fused to the C terminal of an IgG of anti-CD300 antibody, or vice versa. The format retains desired characteristics of intact antibodies. This BsAb canreduce eosinophil signaling, inhibit bronchoalveolar lavage fluid inflammation, eosinophil, mast cell mediator release and reverse lung inflammation. It is designed for the research of Asthma therapy.

Datasheet INQUIRY

Specifications

Targets

CCR3 & CD300

Type

IgG-Fv

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Asthma

Targets

Target 1

CCR3

Gene ID

1232

UniProt ID

P51677

Alternative Names

CCR3; C-C motif chemokine receptor 3; CKR3; CD193; CMKBR3; CC-CKR-3

Target 2

CD300

Gene ID

11314

UniProt ID

Q9UGN4

Alternative Names

CD300A; CD300a molecule; IRC1; IRC2; CLM-8; IRp60; IGSF12; CMRF35H; CMRF-35H; CMRF35-H; CMRF35H9; CMRF35-H9; IRC1/IRC2; CMRF-35-H9

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-CCR3 x Anti-CD300 Bispecific Antibody (IgG-Fv) (BSGV-028). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-CCR3 x Anti-CD300 Bispecific Antibody (IgG-Fv) (CAT#: BSGV-028)

Specifications

Targets

Customer Reviews and Q&As